17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Related
The FTI Journal continues its look at opportunities for private equity in distressed M&A given the p...
Read More >
As life under lockdown begins to feel like the 'new norm', we have created two snapshots of the key ...
Read More >
Wilson Sonsini Goodrich & Rosati (Wilson Sonsini) is pleased to present its 2019 Antitrust Year in R...
Read More >
Reversing the trial court, the Delaware Supreme Court has held that an appraisal proceeding does not...
Read More >
Recent notable industry transactions. The Alan Turing Institute, the Royal Statistical Society and ...
Read More >
The U.S. Equal Employment Opportunity Commission (EEOC) has sued Yale New Haven Hospital based on th...
Read More >